Cargando…

Efficacy and Safety of Drotaverine Hydrochloride in Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Study

BACKGROUNDS/AIMS: To study the efficacy and safety of drotaverine hydrochloride (HCl) 80 mg tablet given thrice a day in the symptomatic relief of patients with irritable bowel syndrome (IBS). PATIENTS AND METHODS: The study was a multicentric, randomized, double-blind, placebo-controlled parallel g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rai, Ramesh R., Dwivedi, Manisha, Kumar, Nirmal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271014/ https://www.ncbi.nlm.nih.gov/pubmed/25434320 http://dx.doi.org/10.4103/1319-3767.145331

Ejemplares similares

Randomized controlled study of efficacy and safety of drotaverine hydrochloride in patients with irritable bowel syndrome
por: Xue, Xing-cun, et al.
Publicado: (2017)

Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study
por: Rai, Ramesh R., et al.
Publicado: (2021)

Neuromuscular electrical stimulation as an adjunctive therapy to drotaverine hydrochloride for treating patients with diarrhea-predominant irritable bowel syndrome: A retrospective study
por: Wang, Jian-kui, et al.
Publicado: (2018)

Simultaneous Spectrophotometric Determination of Drotaverine Hydrochloride and Paracetamol in Tablet
por: Mahaparale, Sonali, et al.
Publicado: (2010)

Drotaverine to shorten the duration of labour in primigravidas: a randomised, double-blind, placebo-controlled trial
por: Ikeotuonye, Arinze Chidiebele, et al.
Publicado: (2022)

Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Oh, Joo Hyun, et al.
Publicado: (2019)

Compatibility of Drotaverine Hydrochloride with Ibuprofen and Ketoprofen Nonsteroidal Anti-Inflammatory Drugs Mixtures
por: Soare, Andreia-Cristina, et al.
Publicado: (2022)

Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double‐blind, placebo‐controlled phase 2 trial
por: Lacy, Brian E., et al.
Publicado: (2022)

Drotaverine-induced priapism
por: Kanbur, Ajay Shyam, et al.
Publicado: (2021)

Development and Validation of Simultaneous Spectrophotometric Methods for Drotaverine Hydrochloride and Aceclofenac from Tablet Dosage Form
por: Shah, S. A., et al.
Publicado: (2011)

Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
por: Vázquez-Frias, Rodrigo, et al.
Publicado: (2022)

A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
por: Khalilian, Alireza, et al.
Publicado: (2021)

Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study
por: Kim, Hee-Young, et al.
Publicado: (2022)

Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]
por: Gupta, Anil Kumar, et al.
Publicado: (2021)

Intramuscular Administration of Drotaverine Hydrochloride Decreases Both Incidence of Urinary Retention and Time to Micturition in Orthopedic Patients under Spinal Anesthesia: A Single Blinded Randomized Study
por: Tomaszewski, Dariusz, et al.
Publicado: (2015)

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a bupivacaine hydrochloride implant in patients undergoing abdominoplasty
por: Beaton, Alina C, et al.
Publicado: (2023)

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial
por: Ivashkin, Vladimir T., et al.
Publicado: (2022)

Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub‐cohort analysis of a phase III, randomized, double‐blind, placebo‐controlled trial
por: Peng, Li Hua, et al.
Publicado: (2022)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: Zhu, Jia-Jie, et al.
Publicado: (2016)

A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation
por: Mezzasalma, Valerio, et al.
Publicado: (2016)

A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis
por: Bousquet, Jean, et al.
Publicado: (2023)

Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial
por: Zanwar, Vinay G, et al.
Publicado: (2016)

The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
por: Shin, Seung Yong, et al.
Publicado: (2020)

Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial
por: Bordbar, Ghasem, et al.
Publicado: (2020)

The Efficacy of Shugan Jianpi Zhixie Therapy for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: Xiao, Ya, et al.
Publicado: (2015)

Corrigendum to “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation”
por: Mezzasalma, Valerio, et al.
Publicado: (2019)

Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial
por: Zheng, Ya, et al.
Publicado: (2021)

Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Jalili, Mahsa, et al.
Publicado: (2019)

Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
por: Ballou, Sarah, et al.
Publicado: (2017)

The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial
por: Bai, Tao, et al.
Publicado: (2020)

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
por: Kemppinen, Anu, et al.
Publicado: (2020)

Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium
por: Lee, Kang Nyeong, et al.
Publicado: (2014)

Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial
por: Shahbazkhani, Bijan, et al.
Publicado: (2015)

Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study
por: Shin, Dong Woo, et al.
Publicado: (2018)

The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study
por: Faghih Dinevari, Masood, et al.
Publicado: (2023)

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials
por: Schoenfeld, P., et al.
Publicado: (2014)

Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial
por: Ricci, Chiara, et al.
Publicado: (2022)

Randomized, double-blinded, placebo-controlled trial evaluating simethicone pretreatment with bowel preparation during colonoscopy
por: Rishi, Mohit, et al.
Publicado: (2019)

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study
por: Lee, Ju Yup, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eq7vdb0aovvs2gqf6f1rln5i9t